News stories about Intermolecular (NASDAQ:IMI) have been trending somewhat positive on Sunday, Accern reports. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Intermolecular earned a coverage optimism score of 0.21 on Accern’s scale. Accern also gave news articles about the semiconductor company an impact score of 45.3501267856852 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Separately, ValuEngine upgraded Intermolecular from a “strong sell” rating to a “sell” rating in a research report on Monday, August 7th.
Intermolecular (IMI) remained flat at $0.90 on Friday. The company’s stock had a trading volume of 31,537 shares. The firm’s market cap is $44.60 million. The firm has a 50 day moving average price of $0.91 and a 200-day moving average price of $0.92. Intermolecular has a 52-week low of $0.78 and a 52-week high of $1.20.
In other Intermolecular news, major shareholder Lloyd I. Miller III bought 34,109 shares of the firm’s stock in a transaction dated Friday, September 1st. The shares were acquired at an average cost of $0.86 per share, for a total transaction of $29,333.74. Following the transaction, the insider now owns 70,368 shares in the company, valued at $60,516.48. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Lloyd I. Miller III bought 80,000 shares of the firm’s stock in a transaction dated Thursday, June 22nd. The shares were acquired at an average price of $0.88 per share, for a total transaction of $70,400.00. Following the completion of the transaction, the insider now owns 70,368 shares in the company, valued at approximately $61,923.84. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 125,589 shares of company stock worth $109,607. 45.40% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was first posted by BBNS and is the property of of BBNS. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://baseballnewssource.com/markets/intermolecular-imi-given-news-impact-score-of-0-21/1554220.html.
Intermolecular Company Profile
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with our FREE daily email newsletter.